Issue link: https://www.e-digitaleditions.com/i/1509606
A point of view article considers a roadmap for sustainable inhaler use in the UK that could support the NHS net zero ambition. An interview discusses the inhalation community’s reaction to a series of articles about limitations in metrics commonly used in regulation of APSDs. The interview is supported by an article about cascade impactor stage groupings. 2 OctOber 2023 Inhalation Inhalation (ISSN 1940-414X digital) is published seven times per year in January, February, April, June, August, October and December by Whipsnade and Loophole, LLC, P.O. Box 27092, Minneapolis, MN 55427 US. w w w . i n h a l a t i o n m a g . c o m October 2023 Volume 17 Number 5 The cover photo shows the MRX006, a multi-dose dry powder inhaler. Courtesy of Merxin Ltd., 1 Innovation Drive, King's Lynn, PE30 5BY, United Kingdom, Tel.: +44 1553 403070, info@merxin.com, www.merxin.com devices 10 Limitations of metrics used in the regulation of aerodynamic particle size distributions (APSDs) of orally inhaled products (OIPs) Adrian P. Goodey, Jolyon P. Mitchell, William H. Doub, J. David Christopher and Ian Carter 13 Cascade impactor stage groupings: Poor decisions from degraded data Adrian P. Goodey, Jolyon P. Mitchell, William H. Doub and J. David Christopher 23 Issue focus: Devices 27 Point of view: A proposed roadmap for sustainable inhaler use in the UK that could support the NHS net zero ambition Alex Wilkinson and Gregor Anderson outsoucing services 34 Special section: Outsoucing services additional features 6 Cross-industry organizations: A review of RDD ® Europe 2023 and look ahead to RDD 2024 The Organizers of the Respiratory Drug Delivery Conference Series 9 Previewing DDL2023 39 Back pages: Non-profits create program to empower young people who have asthma Need for food allergy awareness on college campuses in the US departments 8 Industry news 37 Respiratory medicine news 37 Calendar 38 White papers and webinars